Importantly, we also identify YB-1 as a transcriptional regulator of drug resistance-related gene ABCB1 and provide evidence to support a function for YB-1 in intrinsic cellular resistance to various anti-cancer therapies, both related to and separate from its aforementioned role as a regulator of the ABCB1 gene. Here, ABCB1 is linked to cancer.